Summary
Objective: To evaluate QoL in a sample of Brazilian patients with Gaucher (GD) and Fabry (FD) disease using the SF-36 survey.
Method: Observational cross-sectional study. The SF-36 survey was administered to cognitively able patients 12 years or older, who were seen in the Medical Genetics Service of Hospital de Clínicas de Porto Alegre, Brazil.
Results: Thirty-five patients were included in the study (GD = 21, FD = 14), mean age was 29.8 ± 14.2 years and 29 (82.9%) were receiving ERT. Patients with GD receiving ERT had better scores in the general health (p = 0.046) domain of the SF-36 than patients with FD receiving ERT. Comparison of patients with GD naive to ERT and those receiving ERT revealed differences only in the bodily pain domain (p = 0.036). The Zimran score showed a moderate negative correlation with the following domains of the SF-36: physical functioning (p = 0.035), role-physical (p = 0.036), general health (p = 0.023) and role emotional (p = 0.021).
Discussion and Conclusion: Although limited because of the small number of patients included, findings suggest that patients with GD receiving ERT have a better QoL than patients with FD or with GD not receiving ERT. Imiglucerase has a beneficial effect against pain for patients with GD. Further studies should be conducted to confirm our findings.
Competing interests: None declared
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR (1997) Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reumatol 39:50
Damiano AM, Pastores GM, Ware JE (1998) The health-related quality of life of adults with Gaucher’s disease receiving enzyme replacement therapy: results from a retrospective study. Qual Life Res 7:373–386
Gieselmann V (1995) Lysosomal storage diseases. Biochim Biophys Acta 1270:103–136
Giraldo P, Pocoví M, Pérez-Calvo J, Rubio-Félix D, Giralt M (2000) Report of the Spanish Gaucher’s Disease Registry: clinical and genetic characteristics. Haematologica 85:792–799
Giraldo P, Solano V, Pérez-Calvo JI, Giralt M, Rubio-Félix D, Spanish Group on Gaucher Disease (2005) Quality of life related to type 1 Gaucher disease: Spanish experience. Qual Life Res 14:453–462
Hsiung PC, Fang CT, Chang YY, Chen MY, Wang JD (2005) Comparison of WHOQOL-bREF and SF-36 in patients with HIV infection. Qual Life Res 14:141–150
Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE Jr (2000) Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 43:1478–1487
Lima MG, Barros MB, Cesar CL, Goldbaum M, Carandina L, Ciconelli RM (2009) Health related quality of life among the elderly: a population-based study using SF-36 survey. Cad Saude Publica 25:2159–2167
Masek BJ, Sims KB, Bove CM, Korson MS, Short P, Norman DK (1999) Quality of life assessment in adults with type 1 Gaucher disease. Qual Life Res 8:263–268
McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247–263
Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999a) Prevalence of lysosomal storage disorders. JAMA 281:249–254
Meikle PJ, Ranieri E, Ravenscroft EM, Hua CT, Brooks DA, Hopwood JJ (1999b) Newborn screening for lysosomal storage disorders. Southeast Asian J Trop Med Public Health 30(Suppl 2):104–110
Panzini RG, Bandeira DR (2005) Quality of life and spiritual-religious coping relations. Qual Life Res 14:2106–2107
Pastores GM, Barnett NL, Bathan P, Kolodny EH (2003) A neurological symptom survey of patients with type I Gaucher disease. J Inherit Metab Dis 26:641–645
Pinto LL, Vieira TA, Giugliani R, Schwartz IV (2010) Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review. Orphanet J Rare Dis 5:14
Poorthuis BJ, Wevers RA, Kleijer WJ et al (1999) The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105:151–156
Raas-Rothschild A, Pankova-Kholmyansky I, Kacher Y, Futerman AH (2004) Glycosphingolipidoses: beyond the enzymatic defect. Glycoconj J 21:295–304
Streiner DL, Norman GR (1995) Health measurement scales: a practical guide to their development and use. Oxford University Press, Oxford
The WHOQOL Group (1994) Development of the WHOQOL: rationale and current status. Int J Ment Health 23:24–56
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483
Ware JE, Snow KK, Kosinski M et al (1993) SF-36 health survey. Manual and interpretation guide. New England Medical Center, Boston
Weinreb N, Barranger J, Packman S et al (2007) Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease. Clin Genet 71:576–588
Wraith JE (2002) Lysosomal disorders. Semin Neonatol 7:75–83
Zimran A, Kay A, Gelbart T, Garver P, Thurston D, Saven A, Beutler E (1992) Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine 71:337–53
Acknowledgments
The authors thank the staff of the Medical Genetics Service of HCPA and the staff of the Reference Center for Gaucher Disease for their support and collaboration in the conduction of this study. We also thank the Research and Graduate Program of HCPA, Porto Alegre, Brazil, for their support and preparation of statistical analysis, especially the statistician Marilyn Agranonik.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Ed Wraith
Appendices
Synopsis of the Article
This study evaluated the quality of life of patients with Gaucher and Fabry diseases using a nonspecific instrument, the SF-36 questionnaire. Results suggested that ERT has a positive effect against the pain domain for patients with Gaucher disease.
Authors Contributions
Fabiane Lopes Oliveira Conception and design, analysis and interpretation of data, drafting of the article.
Taciane Alegra Analysis and interpretation of data, drafting of the article.
Alicia Dornelles Analysis and interpretation of data, drafting of the article.
Bárbara Corrêa Krug Analysis and interpretation of data, drafting of the article.
Cristina B. O. Netto Analysis and interpretation of data, drafting of the article.
Neusa Sica da Rocha Analysis and interpretation of data, drafting of the article.
Paulo D. Picon Analysis and interpretation of data, drafting of the article.
Ida Vanessa D. Schwartz Conception and design, analysis and interpretation of data, drafting of the article.
Guarantor for the Article
Ida Vanessa D. Schwartz.
Competing Interest
All authors declare that the answer to all questions on the JIMD competing interest form is No, and therefore they have nothing to declare.
Funding
This study was partially funded by FIPE/HCPA, Porto Alegre, Brazil (project # 08-209), and by grants from the Brazilian Agency of Research-CNPq (MCT/CNPq/MS-SCTIE-DECIT 33/2007; MCT/CNPq/MS-SCTIE-DECIT 37/2008; and MCT/CNPq/MS-SCTIE-DECIT 67/2009).
Ethics Approval
This study was approved by the Ethics in Research Committee of the Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Patient Consent
All patients or their guardians signed an informed consent form.
Rights and permissions
Copyright information
© 2012 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Oliveira, F.L. et al. (2012). Quality of Life of Brazilian Patients with Gaucher Disease and Fabry Disease. In: Brown, G., Morava, E., Peters, V., Gibson, K., Zschocke, J. (eds) JIMD Reports - Case and Research Reports, 2012/4. JIMD Reports, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_136
Download citation
DOI: https://doi.org/10.1007/8904_2012_136
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-32441-3
Online ISBN: 978-3-642-32442-0
eBook Packages: MedicineMedicine (R0)